Besides the downregulation of ADAM10 by miR-655-3p in inhibitory activity on the proliferation, invasion, and metastasis of hepatoma cells 30, our investigations suggest a new insight into the regulation of ADAM10 expression by miR-891a-5p in breast cancer cells. Here, ADAM10 is linked to hepatocellular carcinoma.